Dutchie IPO: Revenue, Investors, Valuation & How to Invest

What is Dutchie?

Dutchie is a cannabis technology company founded in 2017 and based in Bend, Oregon. It builds software that powers legal cannabis retail, covering e-commerce, point-of-sale, payments and compliance tools used by thousands of dispensaries across the US and Canada. By late 2022 it already had more than 5,000 retail clients and processed about $14 billion in annual sales, according to MJBizDaily.

The company is often described as aiming to be the “Shopify for cannabis dispensaries”: it lets dispensaries publish menus online, take orders for delivery or in-store pickup, manage inventory, and stay compliant with each state’s regulations. Because Dutchie is a software middleman rather than a grower or producer, its exposure to the direct regulatory and operational risks of cannabis cultivation and sale is narrower than a pure cannabis play, although it is still closely tied to the legal cannabis industry’s overall health.

Dutchie has scaled alongside the wave of US state-level cannabis legalisation. At federal level, a December 2025 executive order led to an April 2026 DEA final order that moved FDA-approved marijuana products and state-licensed medical marijuana to Schedule III. Adult-use (recreational) marijuana remains in Schedule I, and a broader rescheduling is still under review after a DEA hearing that began in June 2026. The company has historically attracted significant interest from technology investors who see it as potentially becoming the dominant infrastructure provider for legal cannabis retail.

Dutchie generates most of its revenue from selling software subscriptions and services to dispensaries. The software helps them more effectively and efficiently:

• Take and process sales orders.
• Manage stock and inventory.
• Comply with state-specific cannabis regulations.
• Process payments and monitor cash flow.
• Run loyalty programmes and marketing campaigns.

Dutchie key company facts

Dutchie company statistics

Below is a breakdown of some key figures, including Dutchie’s revenue, funding, competitors and investors.

Dutchie revenue

Revenue figures are estimates based on third-party reporting, since Dutchie is privately held and doesn’t publish audited financials. The cannabis sector has faced depressed valuations and slower growth than expected since 2022, and Dutchie cut about 8% of its workforce (67 employees) in June 2022, citing a “dramatic market shift”.

Dutchie funding and valuation history

Total primary funding raised stands at about $603 million across Seed through Series D. The cannabis-sector downturn since 2022 has weighed on Dutchie’s mark-to-market valuation.

Dutchie’s competitors

The cannabis software space has matured significantly since Dutchie’s early days, with growing competition across e-commerce, point-of-sale, payments, and back-office functions. The legal cannabis industry continues to expand, with US legal sales worth tens of billions of dollars a year.

Here are some of the key competitors Dutchie faces across various segments of cannabis retail technology:

• Weedmaps (WM Technology, Nasdaq: MAPS): a publicly traded cannabis tech company focused on consumer discovery and dispensary marketing.
• Leafly: cannabis information and marketplace platform.
• Flowhub: point-of-sale and compliance software for dispensaries.
• Treez: enterprise retail software for cannabis operators.
• Cova Software: point-of-sale and compliance platform popular in Canada and the US.
• Meadow: integrated retail platform focused mainly on California.
• BLAZE: cannabis ERP (enterprise resource planning), point-of-sale and delivery software.
• Eaze: cannabis delivery marketplace, more direct-to-consumer than B2B (business-to-business).
• Springbig: cannabis-focused marketing automation and loyalty software.

Note that this is an evolving competitive landscape: some companies, such as Weedmaps, are publicly listed, while others remain private. Cannabis software has also seen consolidation, with Dutchie itself acquiring competitors like Greenbits and LeafLogix in 2021.

Dutchie’s top investors

As a private company, Dutchie is backed by a mix of venture capitalists, institutional investors, and high-profile individuals. Major backers across its funding rounds include:

• D1 Capital Partners: led the $350M Series D round in October 2021.
• Tiger Global Management: led the Series C round in March 2021.
• DFJ Growth
• Dragoneer Investment Group
• Thrive Capital
• Casa Verde Capital: the cannabis-focused VC (venture capital) firm co-founded by Snoop Dogg.
• Gron Ventures
• Glynn Capital Management
• Willoughby Capital
• Park West Asset Management
• Bracket Capital
• Thirty Five Ventures: the investment firm founded by NBA player Kevin Durant.

The combination of mainstream venture capital firms (Tiger Global, D1, Thrive, Dragoneer) and cannabis-specialist investors (Casa Verde, Gron Ventures) has been a notable feature of Dutchie’s investor base, reflecting the company’s positioning as a “picks and shovels” software play on cannabis legalisation rather than a direct cannabis producer.

When is the Dutchie IPO?

There’s no confirmed date for a Dutchie IPO. The right moment for the company to go public will depend on several factors:

• The regulatory environment for cannabis in the US, including whether the DEA extends Schedule III beyond medical marijuana and any future moves toward federal legalisation.
• Better conditions for tech and growth IPOs, including stable interest rates, manageable inflation, and improved investor appetite for unprofitable growth companies.
• Stronger fundamentals at Dutchie itself, particularly a clearer path to profitability, after layoffs and a change of leadership in 2022.

It’s been several years since Dutchie’s last primary funding round (the $350M Series D in October 2021), and the company’s current valuation is reported to be lower than the $3.75 billion peak, reflecting the broader cannabis-sector downturn since 2022. In late 2022, the board also removed co-founders Ross and Zach Lipson and appointed Tim Barash as CEO, and the founders sued the company’s leaders over their removal.

That said, the April 2026 move of medical marijuana to Schedule III was a positive step for the industry, as it removes the Section 280E tax penalty for state-licensed medical operators. A broader rescheduling covering adult-use cannabis, or federal legalisation, could further improve sentiment around cannabis-related IPOs, including Dutchie’s. For now, prospective investors should expect the timeline to remain uncertain, and watch for any signs of an S-1 filing or fresh funding round.

How to invest and buy shares after the Dutchie IPO

After the Dutchie IPO date, you can freely buy the newly listed stock. Interactive Brokers and eToro are two top-rated brokers where you can access Dutchie shares and buy the stock with low fees after the IPO. Take a look at both these brokerage options below:

#1 Interactive Brokers

Founded in 1978, listed on Nasdaq (ticker: IBKR) and part of the S&P 500 since August 2025, Interactive Brokers gives you access to 170 markets in 40 countries, with the ability to trade virtually any asset class: stocks, ETFs, bonds, forex, funds, commodities, options, futures, CFDs, and even micro-cap stocks. It’s a popular choice among investors looking to participate in major IPOs given its broad market access and competitive commissions.

If you want to buy Dutchie stock once the IPO happens, here’s how you’d do it through Interactive Brokers:

1. Open a trading account with Interactive Brokers (the process is fully digital and there’s no minimum deposit).
2. Deposit funds into your account.
3. Once the IPO has priced and trading begins, search for the stock by company name or ticker (Dutchie’s ticker hasn’t yet been confirmed, but will be announced ahead of the listing).
4. Place the order type you wish to use (market, limit, stop, etc.). For volatile IPO debuts, a limit order can help avoid paying an unexpectedly high opening price.
5. Once you’ve bought your desired number of shares, monitor your position and rebalance as needed.

Getting shares at the IPO price itself is harder, as allocations go mostly to institutional investors. For most retail investors, buying on the open market once trading begins is the more accessible route.

If you’d like to learn more about the platform, check out our full-length Interactive Brokers review.

#2 eToro

Founded in 2007, eToro has around 40 million registered users and 4.28 million funded accounts, and it listed on Nasdaq (ticker: ETOR) in May 2025. The platform is widely known for its social and copy-trading features, and lets users trade stocks, ETFs, cryptocurrencies, commodities, forex, and CFDs.

If you’re planning to buy Dutchie stock after the IPO, here’s how you can buy shares through eToro:

1. Open an account with eToro.
2. Go to the “Markets” section and select “Stocks.”
3. Search for the stock by company name or ticker once it’s available.
4. Select “Trade.”
5. Choose how much you want to invest (eToro supports fractional shares, so you can invest a fixed amount rather than buying a whole share).
6. Ensure leverage is set to X1 if you want to buy the actual stock rather than a CFD.
7. Optionally set take-profit or stop-loss levels to automate future actions.
8. Click “Open Trade” to place the order.

Note that US stock trades on eToro carry a $1 commission per trade (ETFs remain commission-free, and other fees apply), and a currency conversion fee of 0.75% applies if you fund your account in euros or pounds.

If you’d like to learn more about the platform, check out our in-depth eToro review.

Bottom line on investing in the Dutchie IPO

Although the Dutchie IPO date is yet to be announced, the company remains a potentially interesting way to gain exposure to the legal cannabis industry. There’s an old saying that the people who make the most money during a gold rush are the ones selling shovels, not those digging for gold, and Dutchie’s “picks and shovels” software role could fit that pattern if the industry continues to expand.

The legal cannabis industry may keep growing, helped by the April 2026 move of medical marijuana to Schedule III in the US, although adult-use cannabis remains federally illegal. However, picking individual winning growers or producers is difficult, and a software infrastructure provider like Dutchie can in theory benefit from broader industry growth without being tied to the success of any single operator.

That said, several real risks need to be considered:

• Competition: Dutchie faces growing competition from Weedmaps, Leafly, Flowhub, Treez, Cova, BLAZE and others, so its long-term lead is not guaranteed.
• Profitability: Dutchie doesn’t publish its financials, and it cut staff in 2022 despite raising about $603M. A path to sustainable profitability has yet to be demonstrated publicly.
• Valuation reset: Dutchie’s last primary funding round was in October 2021 at a $3.75B valuation. Its valuation is reportedly lower now, reflecting the broader cannabis-sector downturn.
• Federal legalisation cuts both ways: while full US federal legalisation would be a major positive for the industry, it could also attract significantly larger, well-resourced players (including big-tech and traditional retail) into the cannabis software space.

Buying shares in Dutchie after an eventual IPO could offer broad exposure to the legal cannabis industry through a software model rather than a direct cannabis play. As with any speculative growth investment, it’s worth keeping position sizes appropriate to your risk tolerance, and watching for an S-1 filing or fresh funding round before committing.